- Home
- MFIC vs BGM Comparison
MFIC vs BGM Comparison
Compare MFIC & BGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFIC
- BGM
- Stock Information
- Founded
- MFIC 2004
- BGM 2019
- Country
- MFIC United States
- BGM China
- Employees
- MFIC N/A
- BGM N/A
- Industry
- MFIC Finance/Investors Services
- BGM
- Sector
- MFIC Finance
- BGM
- Exchange
- MFIC Nasdaq
- BGM NYSE
- Market Cap
- MFIC 1.0B
- BGM 1.0B
- IPO Year
- MFIC 2004
- BGM 2021
- Fundamental
- Price
- MFIC $12.15
- BGM $11.03
- Analyst Decision
- MFIC Hold
- BGM
- Analyst Count
- MFIC 5
- BGM 0
- Target Price
- MFIC $13.25
- BGM N/A
- AVG Volume (30 Days)
- MFIC 336.9K
- BGM 30.9K
- Earning Date
- MFIC 05-12-2025
- BGM 05-20-2025
- Dividend Yield
- MFIC 12.52%
- BGM N/A
- EPS Growth
- MFIC N/A
- BGM N/A
- EPS
- MFIC 1.27
- BGM N/A
- Revenue
- MFIC $301,782,000.00
- BGM $25,097,951.00
- Revenue This Year
- MFIC $15.35
- BGM N/A
- Revenue Next Year
- MFIC $2.93
- BGM N/A
- P/E Ratio
- MFIC $9.58
- BGM N/A
- Revenue Growth
- MFIC 9.13
- BGM N/A
- 52 Week Low
- MFIC $10.18
- BGM $2.70
- 52 Week High
- MFIC $16.36
- BGM $14.78
- Technical
- Relative Strength Index (RSI)
- MFIC 52.66
- BGM 50.51
- Support Level
- MFIC $11.82
- BGM $10.17
- Resistance Level
- MFIC $12.09
- BGM $11.82
- Average True Range (ATR)
- MFIC 0.20
- BGM 0.63
- MACD
- MFIC 0.09
- BGM -0.03
- Stochastic Oscillator
- MFIC 89.02
- BGM 54.21
About MFIC MidCap Financial Investment Corporation
MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.